These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 2974027

  • 1. Different expression of CD3 and CD22 in leukemic cells according to whether tested in suspension or fixed on slides.
    Rani S, De Oliveira MS, Catovsky D.
    Hematol Pathol; 1988; 2(2):73-8. PubMed ID: 2974027
    [Abstract] [Full Text] [Related]

  • 2. Detection of intracellular lymphoid differentiation antigens by flow cytometry in acute lymphoblastic leukemia.
    Sartor M, Bradstock K.
    Cytometry; 1994 Sep 15; 18(3):119-22. PubMed ID: 7813331
    [Abstract] [Full Text] [Related]

  • 3. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
    Janossy G, Coustan-Smith E, Campana D.
    Leukemia; 1989 Mar 15; 3(3):170-81. PubMed ID: 2465463
    [Abstract] [Full Text] [Related]

  • 4. Cytolysis of leukemic B-cells by T-cells activated via two bispecific antibodies.
    Bohlen H, Manzke O, Patel B, Moldenhauer G, Dörken B, von Fliedner V, Diehl V, Tesch H.
    Cancer Res; 1993 Sep 15; 53(18):4310-4. PubMed ID: 7689932
    [Abstract] [Full Text] [Related]

  • 5. Human hematopoietic cell lines: a model system for study of minimal residual disease detection technique in acute leukemia.
    Koníková E, Kusenda J, Babusíková O, Glasová M.
    Neoplasma; 1995 Sep 15; 42(5):227-34. PubMed ID: 8552200
    [Abstract] [Full Text] [Related]

  • 6. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ, Dolce K, Koopman T, Shuman W, Chun R, Garrett L, Barber L, Avery A.
    Vet Immunol Immunopathol; 2005 Jul 15; 106(3-4):179-96. PubMed ID: 15963817
    [Abstract] [Full Text] [Related]

  • 7. Cytotoxic activity of disulfide-stabilized recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) toward fresh malignant cells from patients with B-cell leukemias.
    Kreitman RJ, Margulies I, Stetler-Stevenson M, Wang QC, FitzGerald DJ, Pastan I.
    Clin Cancer Res; 2000 Apr 15; 6(4):1476-87. PubMed ID: 10778980
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy.
    Ghetie MA, May RD, Till M, Uhr JW, Ghetie V, Knowles PP, Relf M, Brown A, Wallace PM, Janossy G.
    Cancer Res; 1988 May 01; 48(9):2610-7. PubMed ID: 2451562
    [Abstract] [Full Text] [Related]

  • 9. Flow cytometric analysis of cell-surface and intracellular antigens in leukemia diagnosis.
    Knapp W, Strobl H, Majdic O.
    Cytometry; 1994 Dec 15; 18(4):187-98. PubMed ID: 7534675
    [Abstract] [Full Text] [Related]

  • 10. Bispecific anti-CD22/anti-CD3-ricin A chain immunotoxin is cytotoxic to Daudi lymphoma cells but not T cells in vitro and shows both A-chain-mediated and LAK-T-mediated killing.
    Shen GL, Li JL, Vitetta ES.
    J Immunol; 1994 Mar 01; 152(5):2368-76. PubMed ID: 8133047
    [Abstract] [Full Text] [Related]

  • 11. Acute kidney graft rejection. A morphological and immunohistological study on "zero-hour" and follow-up biopsies with special emphasis on cellular infiltrates and adhesion molecules.
    Andersen CB, Ladefoged SD, Larsen S.
    APMIS; 1994 Jan 01; 102(1):23-37. PubMed ID: 7513171
    [Abstract] [Full Text] [Related]

  • 12. Low- versus high-dose radioimmunotherapy with humanized anti-CD22 or chimeric anti-CD20 antibodies in a broad spectrum of B cell-associated malignancies.
    Behr TM, Wörmann B, Gramatzki M, Riggert J, Gratz S, Béhé M, Griesinger F, Sharkey RM, Kolb HJ, Hiddemann W, Goldenberg DM, Becker W.
    Clin Cancer Res; 1999 Oct 01; 5(10 Suppl):3304s-3314s. PubMed ID: 10541379
    [Abstract] [Full Text] [Related]

  • 13. Simultaneous expression of CD13, CD22 and CD25 is related to the expression of Fc epsilon R1 in non-lymphoid leukemia.
    Sato N, Kishi K, Toba K, Watanabe K, Itoh H, Narita M, Takahashi M, Aizawa Y.
    Leuk Res; 2004 Jul 01; 28(7):691-8. PubMed ID: 15158090
    [Abstract] [Full Text] [Related]

  • 14. Epratuzumab, a humanized monoclonal antibody targeting CD22: characterization of in vitro properties.
    Carnahan J, Wang P, Kendall R, Chen C, Hu S, Boone T, Juan T, Talvenheimo J, Montestruque S, Sun J, Elliott G, Thomas J, Ferbas J, Kern B, Briddell R, Leonard JP, Cesano A.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 2):3982S-90S. PubMed ID: 14506197
    [Abstract] [Full Text] [Related]

  • 15. CD22 as a target of passive immunotherapy.
    Cesano A, Gayko U.
    Semin Oncol; 2003 Apr 01; 30(2):253-7. PubMed ID: 12720147
    [Abstract] [Full Text] [Related]

  • 16. Concomitant delineation of surface Ig, B-cell differentiation antigens, and HLADR on lymphoid proliferations using three-color immunocytometry.
    Segal GH, Edinger MG, Owen M, McNealis M, Lopez P, Perkins A, Linden MD, Fishleder AJ, Stoler MH, Tubbs RR.
    Cytometry; 1991 Apr 01; 12(4):350-9. PubMed ID: 1712263
    [Abstract] [Full Text] [Related]

  • 17. Methods in pathology. Identification of T-cell lymphomas in paraffin-embedded tissues using polyclonal anti-CD3 antibody: comparison with frozen section immunophenotyping and genotypic analysis.
    Anderson C, Rezuke WN, Kosciol CM, Pastuszak WT, Cartun RW.
    Mod Pathol; 1991 May 01; 4(3):358-62. PubMed ID: 1829834
    [Abstract] [Full Text] [Related]

  • 18. The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils, and monocytes.
    Engel P, Nojima Y, Rothstein D, Zhou LJ, Wilson GL, Kehrl JH, Tedder TF.
    J Immunol; 1993 Jun 01; 150(11):4719-32. PubMed ID: 7684411
    [Abstract] [Full Text] [Related]

  • 19. Myeloid lineage involvement in acute lymphoblastic leukemia: a morphology antibody chromosomes (MAC) study.
    Larramendy M, el-Rifai W, Saarinen U, Alitalo R, Luomahaara S, Knuutila S.
    Exp Hematol; 1995 Dec 01; 23(14):1563-7. PubMed ID: 8542947
    [Abstract] [Full Text] [Related]

  • 20. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
    Belov L, de la Vega O, dos Remedios CG, Mulligan SP, Christopherson RI.
    Cancer Res; 2001 Jun 01; 61(11):4483-9. PubMed ID: 11389079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.